These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 11869841

  • 1. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
    Grimm W, Hoffmann J Jü, Müller HH, Maisch B.
    J Am Coll Cardiol; 2002 Mar 06; 39(5):780-7. PubMed ID: 11869841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
    Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.
    Clin Cardiol; 2011 Oct 06; 34(10):604-9. PubMed ID: 21887690
    [Abstract] [Full Text] [Related]

  • 5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.
    J Cardiovasc Electrophysiol; 2012 Mar 06; 23(3):296-301. PubMed ID: 21955243
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep 06; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 8. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.
    J Am Coll Cardiol; 1999 May 06; 33(6):1596-601. PubMed ID: 10334430
    [Abstract] [Full Text] [Related]

  • 9. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
    Pires LA, May LM, Ravi S, Parry JT, Lal VR, Nino CL.
    Am J Cardiol; 2000 Mar 15; 85(6):725-8. PubMed ID: 12000047
    [Abstract] [Full Text] [Related]

  • 10. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W, Christ M, Bach J, Müller HH, Maisch B.
    Circulation; 2003 Dec 09; 108(23):2883-91. PubMed ID: 14623812
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug 09; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 14. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
    Rosenthal TM, Stahls PF, Abi Samra FM, Bernard ML, Khatib S, Polin GM, Xue JQ, Morin DP.
    Heart Rhythm; 2015 Aug 09; 12(8):1789-97. PubMed ID: 25998895
    [Abstract] [Full Text] [Related]

  • 15. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
    Piers SR, Everaerts K, van der Geest RJ, Hazebroek MR, Siebelink HM, Pison LA, Schalij MJ, Bekkers SC, Heymans S, Zeppenfeld K.
    Heart Rhythm; 2015 Oct 09; 12(10):2106-14. PubMed ID: 26004942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
    Zhu DW, Sun H, Hill R, Roberts R.
    Pacing Clin Electrophysiol; 1998 Jan 09; 21(1 Pt 2):299-302. PubMed ID: 9474693
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
    Naruse Y, Nogami A, Shinoda Y, Hanaki Y, Shirai Y, Kowase S, Kurosaki K, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Aonuma K.
    J Cardiovasc Electrophysiol; 2016 Dec 09; 27(12):1448-1453. PubMed ID: 27593399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.